FDA NDC Directory · JSON-LD · Markdown

Levocarnitine

NDC 16571-762 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076858
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOCARNITINE (330 mg/1)
Marketing started20201201
Package count1

External sources

Source: openFDA. Public-domain (CC0).